India to Angola: Clindamycin Export Trade Route
India has recorded 52 verified shipments of Clindamycin exported to Angola, representing a combined trade value of $1.7M USD. This corridor is served by 16 active Indian exporters, with an average shipment value of $33.6K USD. The leading Indian exporter is BIOMATRIX HEALTHCARE PRIVATE LIMITED, which accounts for 89% of total export value with 12 shipments worth $1.6M USD. On the buying side, UNICA FARMA, LDA. is the largest importer in Angola with $1.5M USD in purchases. The top 3 suppliers — BIOMATRIX HEALTHCARE PRIVATE LIMITED, BIOMATRIX HEALTHCARE PRIVATE LIMITED , AURA PHARMACEUTICALS PRIVATE LIMITED — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Angola Clindamycin corridor is one of India's established pharmaceutical export routes, with 52 shipments documented worth a combined $1.7M USD. The route is dominated by BIOMATRIX HEALTHCARE PRIVATE LIMITED, which alone accounts for roughly 89% of all export value, reflecting the consolidated nature of India's clindamycin manufacturing sector.
Across 16 active suppliers, the average shipment value stands at $33.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with clindamycin's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 26.0%, placing it at rank #10 among India's top clindamycin export destinations globally.
On the import side, key buyers of Indian clindamycin in Angola include UNICA FARMA, LDA., UNICA FARMA, LDA. , UNICA FARMA,LDA. and 21 others. UNICA FARMA, LDA. is the single largest importer with 6 shipments valued at $1.5M USD.
Route Characteristics
- Average transit30 days
